40
Participants
Start Date
August 12, 2019
Primary Completion Date
February 20, 2020
Study Completion Date
February 20, 2020
Sugammadex Injection 2mg/kg
Intravenous injection of 2mg/kg of sugammadex sodium 15 minutes after rocuronium administration
Sugammadex Injection 4mg/kg
Intravenous injection of 4mg/kg of sugammadex sodium 15 minutes after rocuronium administration
Sugammadex Injection 8mg/kg
Intravenous injection of 8mg/kg of sugammadex sodium 15 minutes after rocuronium administration
Neuromuscular reversal agent injection
Intravenous injection of 0.02mg/kg of atropine and 0.03mg/kg of neostigmine
SNUH, Seoul
Ministry of Food and Drug Safety, Korea
OTHER_GOV
Seoul National University Hospital
OTHER